ERBB2 and lung carcinoma: Interestingly, in a conditional knockout mouse model, HK2 mediated KRas-driven lung carcinoma and ErbB2-driven generation and maintenance of breast cancer, and HK2 downregulation inhibited lung cancer in vitro and in vivo as well as the malignant biological behavior of breast cancer [32].